Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored vs. Traditional 2nd Line Therapy for H. pylori Eradication
NCT02349685Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jan 2010
- Primary completion
- Jun 2014
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
01
Overview
Open-label trial of bismuth subcitrate, metronidazole, tetracycline, moxifloxacin and amoxicillin in Helicobacter pylori infection, sponsored by Seoul National University Bundang Hospital. Started Jan 2010; status: completed.
02
Drugs
bismuth subcitratemetronidazoletetracyclinemoxifloxacinamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02349685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349685.